Leica Microsystems (Schweiz) AG clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
3 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 1 with a minor change only.
- Stopped: IMED-MYVEO · Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes Withdrawn before enrolling
- Notable: IMED-GLOW400 · Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use Recruitment opened
- Minor: IMED-GLOW800 · Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use Primary completion moved earlier from Dec 31, 2026 to Nov 30, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Glioblastoma (1) · Glioma (1) · Stroke (1)
Get alerts when Leica Microsystems (Schweiz) AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.